The Churchill Hospital is a teaching hospital in Oxford, England. It is managed by the Oxford University Hospitals NHS Foundation Trust.

During the past decade, Churchill Hospital conducted 172 clinical trials. In the 10-year time frame, 172 clinical trials started and 56 clinical trials were completed, i.e. on average, 32.6% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 33 clinical trials were completed. i.e. 54.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Churchill Hospital" #1 sponsor was "Hoffmann-La Roche" with 16 trials, followed by "University of Oxford" with 15 trials sponsored, "University College, London" with 14 trials sponsored, "Oxford University Hospitals NHS Trust" with 10 trials sponsored and "Pfizer" with 10 trials sponsored. Other sponsors include 181 different institutions and companies that sponsored additional 107 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Churchill Hospital" #1 collaborator was "Cancer Research UK" with 23 trials as a collaborator, "AstraZeneca" with 10 trials as a collaborator, "Amgen" with 6 trials as a collaborator, "Pfizer" with 6 trials as a collaborator and "Celgene" with 5 trials as a collaborator. Other collaborators include 206 different institutions and companies that were collaborators in the rest 166 trials.

According to Clinical.Site data, the most researched conditions in "Churchill Hospital" are "Multiple Myeloma" (14 trials), "Ovarian Cancer" (13 trials), "Melanoma" (9 trials), "Breast Cancer" (7 trials) and "Prostate Cancer" (7 trials). Many other conditions were trialed in "Churchill Hospital" in a lesser frequency.

Most popular intervention types in "Churchill Hospital" are "Drug" (192 trials), "Biological" (35 trials), "Other" (22 trials), "Procedure" (17 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Paclitaxel" (9 trials), "Dexamethasone" (7 trials), "Gemcitabine" (7 trials) and "Rituximab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Churchill Hospital" are 214 trials for "All" genders, 20 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Churchill Hospital". undefined are not yet recruiting, 53 are recruiting, 44 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 108 completed trials in Churchill Hospital, 1 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Churchill Hospital, 46 "Phase 1" clinical trials were conducted, 98 "Phase 2" clinical trials and 87 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 18 trials that are defined as “Not Applicable".